The global alopecia treatment (hair loss) market addresses the multifaceted challenges of hair loss through diverse therapeutic interventions. From topical solutions and oral medications to surgical procedures and laser therapy, the market strives to provide effective solutions catering to various causes and degrees of alopecia. Topical minoxidil and oral finasteride remain prominent pharmaceutical interventions, while advancements in hair transplant techniques offer surgical options. Laser therapy and platelet-rich plasma (PRP) treatments showcase emerging trends.
Data Bridge Market Research analyses that the Global Alopecia Treatment (Hair Loss) Market, which was USD 3,614.73 million in 2022, is expected to reach USD 6,266.73 million by 2030, growing at a CAGR of 7.12% during the forecast period of 2023 to 2030.
"Rise in the geriatric population drive the market growth"
The global increase in the geriatric population has generated a heightened demand for alopecia treatment. Age-related hair loss is a common concern among older individuals, impacting appearance and self-esteem. Motivated by a desire to address this issue and maintain a more youthful look, many elderly individuals actively seek effective alopecia treatment options. This rising demand highlights the significance of catering to the specific needs of the aging population in the realm of hair loss solutions.
What restraints the growth of the global alopecia treatment (hair loss) market?
"Side effects hamper the market growth"
The market for alopecia treatments faces a substantial hindrance due to associated side effects. Medications such as minoxidil and finasteride, commonly used for hair loss, can induce scalp irritation and other adverse reactions in some users. These potential side effects evoke health concerns, acting as a deterrent for individuals considering or continuing treatment. Such drawbacks can hamper market growth, as health apprehensions may discourage potential users, impacting the adoption and effectiveness of alopecia treatments.
Segmentation: Global Alopecia Treatment (Hair Loss) Market
The global alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, drug type, gender, age group, form, distribution channel, and end-users.
- On the basis disease type, the global alopecia treatment (hair loss) market is segmented into alopecia areata, cicatricial, traction, androgenetic alopecia, non‒cicatricial alopecia, traction alopecia, ciatricial alopecia, alopecia totalis, alopecia universalis, and others
- On the basis treatment, the global alopecia treatment (hair loss) market is segmented into(localized therapies, medical devices, systemic therapies, herbal treatment, hair transplant services, and low level laser therapy
- On the basis drug type, the global alopecia treatment (hair loss) market is segmented into topical agents, oral drugs, injections, corticosteroids, immunosuppressants, minoxidil, finasteride, and others
- On the basis gender, the global alopecia treatment (hair loss) market is segmented into male, and female
- On the basis age group, the global alopecia treatment (hair loss) market is segmented into below 18 years, 18-34 years, 35-49 years, and above 50 years
- On the basis form, the global alopecia treatment (hair loss) market is segmented into topical, oral, and parenteral.
- On the basis distribution channel, the global alopecia treatment (hair loss) market is segmented into hospital pharmacy, drug stores, dermatology clinics, retail pharmacy, online pharmacy, and others
- On the basis end-users, the global alopecia treatment (hair loss) market is segmented into hospitals, dermatologic and trichology clinics, aesthetic clinics, specialty clinics, homecare, and others
Regional Insights: North America dominates the Global Alopecia Treatment (Hair Loss) Market
North America dominates the global alopecia treatment (hair loss) market and is expected to maintain this dominance. The prevalence of common alopecia and the region's market expansion and influx of new competitors contribute to its leading position. The dynamic growth of the market in North America reflects the ongoing demand and competition within the alopecia treatment sector.
Asia-Pacific is expected to dominate the global alopecia treatment (hair loss) market, experiencing the highest growth rate during the forecast period. The region's increasing adoption of hair care treatments for alopecia and the growing prevalence of hair loss contribute to this dominance. Additionally, improvements in the healthcare regulatory scenario in developing countries are anticipated to attract international players, fostering investment and capitalization on available market opportunities.
Recent Developments: Global Alopecia Treatment (Hair Loss) Market
- In 2021, Pfizer announced the success of Ritlecitinib's phase 2b/3 trial for alopecia treatment. As a covalent kinase inhibitor targeting Janus kinase 3 (JAK3) and tyrosine kinase expressed in hepatocellular carcinoma (TEC) family, Ritlecitinib aims to halt immune cell activity and signaling molecules, addressing a major cause of hair loss
To know more about the study, visit https://www.databridgemarketresearch.com/reports/global-alopecia-treatment-hair-loss-market
The Prominent Key Players Operating in the Global Alopecia Treatment (Hair Loss) Market Include:
- Johnson & Johnson Private Limited (U.S.)
- GlaxoSmithKline plc U.K.)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Cipla Inc. (India)
- Endo International plc (Ireland)
- Zydus Group (India)
- Abbott (U.S.)
- Aurobindo Pharma (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Perrigo Company plc (Ireland)
- Curallux, LLC. (U.S.)
- DR. KURT WOLFF GMBH & CO. KG (Germany)
- WockhardtHospitals (India)
- Sun Pharmaceutical Industries Ltd.(India)
- Concert Pharmaceuticals. (U.S.)
- Cipla Inc. (India)
- DAIICHI SANKYO COMPANY, LIMITED. (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of global alopecia treatment (hair loss) market companies, contact: https://www.databridgemarketresearch.com/contact
Research Methodology: Global Alopecia Treatment (Hair Loss) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
